💊 Accretion Pharmaceuticals at ₹69 – Cheap, Clean, Contract-Manufacturing Machine?
Date of Publishing -
Spotted a factual error — a wrong number, date, or fact? Tell us and we will check the source.
At a Glance
Accretion Pharmaceuticals Ltd is a B2B pharma manufacturer offering tablets, capsules, and third-party formulations for both domestic and global clients. The company just posted a 356% profit growth, 65% ROE, and trades at a P/E of just 11.3x. With improving working capital and big margin expansion — is this India’s next SME breakout?
1. 🧬 Introduction – The Low-Key Compounder Nobody Is Talking About
While the world is busy tracking Sun Pharma’s lawsuits and Divi’s API cycles, Accretion has quietly delivered a ~330% revenue growth and nearly 7x profit in FY25 — all from a humble ₹76 Cr market cap base.
How? Not by reinventing molecules — but by making stuff for people who already did.
2. 🧪 Business Model – WTF Do They Even Do?
👩⚕️ Manufacturing Focus
Tablets
Capsules
Other oral solid dosage forms
🏭 Business Type
Contract manufacturing
Third-party manufacturing
Private label manufacturing
📍 Client Base
Private pharma companies
Government contracts (State + Central)
Institutions (domestic + overseas)
💼 USP: Low-cost, high-quality capacity play for generic pharma. Think of it as India’s Flex for tablets.
